| Bioactivity | NDM-1 inhibitor-3 (Compound 89) is a New Delhi Metallo-β-lactamase-1 (NDM-1) inhibitor with a Ki of 4 μM[1]. |
| Target | NDM-1 |
| Invitro | New Delhi Metallo-β-lactamase-1 (NDM-1), a metallo-β-lactamase (MBL) first discovered at the end of 2008, is now considered as the most clinically relevant target for antibiotic resistance due to its worldwide prevalence[1]. |
| Name | NDM-1 inhibitor-3 |
| Formula | C16H12O4 |
| Molar Mass | 268.26 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Caburet J, et al. A fragment-based drug discovery strategy applied to the identification of NDM-1 β-lactamase inhibitors. Eur J Med Chem. 2022 Jul 11;240:114599. |